Literature DB >> 26704280

[Surgical concepts in the treatment of Wilms tumor: An update].

J Fuchs1.   

Abstract

BACKGROUND: Treatment results of Wilms tumors have been impressively improved over the past 50 years resulting in a stage-independent overall survival of greater than 90%. However, unsatisfying treatment results still remain in children with high-risk tumors and tumor relapses.
MATERIALS AND METHODS: This review highlights the current concepts of Wilms tumor surgery as a cornerstone of the treatment strategy for this malignancy. A selective literature review focusing on the past 5 years served as the basis for this article.
RESULTS: Nephron-sparing surgery is associated with an analogue outcome compared to tumor nephrectomy in unilateral Wilms tumors. The surgical panel of the International Society of Pediatric Oncology (SIOP) group has recently introduced a novel nomenclature for organ-preserving resection procedures in order to facilitate a prospective comparison of data. The minimally invasive approach represents an alternative technique with adequate outcome. In bilateral disease, nephron-sparing procedures are gold standard. Complete resection of lung and liver metastases has a significant impact on patients' survival.
CONCLUSIONS: Surgical guidelines for nephron-sparing surgery and minimally invasive tumor nephrectomy need to be established and implemented within newly formulated treatment protocols of the different national and international treatment trials. Risk stratification of patients needs to be more individualized with the aim of reducing late effects while at least maintaining the same survival rates. The unsatisfying treatment results of tumor relapses-associated with low patient numbers within the different trials-emphasize the need for international collaboration.

Entities:  

Keywords:  Cava thrombosis; Metastases; Minimally invasive surgery; Nephron-sparing surgery; Risk stratification

Mesh:

Year:  2015        PMID: 26704280     DOI: 10.1007/s00120-015-4014-x

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  48 in total

1.  Management of Wilms' tumor with intracardiac extension.

Authors:  S T Schettini; J H da Fonseca; S C Abib; C A Telles; M X Haber; M F Rizzo; N S Saba da Silva; A S Petrilli
Journal:  Pediatr Surg Int       Date:  2000       Impact factor: 1.827

2.  [Reference radiology in nephroblastoma: accuracy and relevance for preoperative chemotherapy].

Authors:  J-P Schenk; C Schrader; B Zieger; R Furtwängler; I Leuschner; S Ley; N Graf; J Troeger
Journal:  Rofo       Date:  2006-01

Review 3.  Risk stratification for wilms tumor: current approach and future directions.

Authors:  Jeffrey S Dome; Elizabeth J Perlman; Norbert Graf
Journal:  Am Soc Clin Oncol Educ Book       Date:  2014

4.  Primary hepatic metastases in nephroblastoma--a report of the SIOP/GPOH Study.

Authors:  Philipp Szavay; Tobias Luithle; Norbert Graf; Rhoikos Furtwängler; Joerg Fuchs
Journal:  J Pediatr Surg       Date:  2006-01       Impact factor: 2.545

Review 5.  Nephron-sparing surgery for bilateral Wilms tumor.

Authors:  Kathleen Kieran; Andrew M Davidoff
Journal:  Pediatr Surg Int       Date:  2015-01-30       Impact factor: 1.827

6.  Nephron-sparing surgery in synchronous bilateral Wilms' tumors.

Authors:  J Fuchs; L Wünsch; P Flemming; P Weinel; H Mildenberger
Journal:  J Pediatr Surg       Date:  1999-10       Impact factor: 2.545

7.  Bilateral Wilms' tumors with progressive or nonresponsive disease.

Authors:  Robert C Shamberger; Gerald M Haase; Pedram Argani; Elizabeth J Perlman; Cecilia A Cotton; Janice Takashima; Daniel M Green; Michael L Ritchey
Journal:  J Pediatr Surg       Date:  2006-04       Impact factor: 2.545

8.  Intravascular extension of Wilms tumor.

Authors:  R C Shamberger; M L Ritchey; G M Haase; T L Bergemann; T Loechelt-Yoshioka; N E Breslow; D M Green
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

9.  Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy.

Authors:  Arnauld Verschuur; Harm Van Tinteren; Norbert Graf; Christophe Bergeron; Bengt Sandstedt; Jan de Kraker
Journal:  J Clin Oncol       Date:  2012-08-27       Impact factor: 44.544

Review 10.  Role of MRI in the management of patients with nephroblastoma.

Authors:  Jens-Peter Schenk; Norbert Graf; Patrick Günther; Sebastian Ley; Maximilian Göppl; Andreas Kulozik; Wiltrud K Rohrschneider; Jochen Tröger
Journal:  Eur Radiol       Date:  2008-01-12       Impact factor: 5.315

View more
  4 in total

Review 1.  [Innovations in surgical treatment of pediatric solid tumors].

Authors:  A Schmidt; S W Warmann; C Urla; J Fuchs
Journal:  Chirurg       Date:  2018-03       Impact factor: 0.955

2.  Expression and clinical significance of p73 in Wilms tumor in children.

Authors:  Yan Ding; Xiaohui Guo; Xinxin Liu; Jitao Li; Ning Li; Cong Xu
Journal:  Oncol Lett       Date:  2019-04-15       Impact factor: 2.967

3.  FOXO3a‑modulated DEPDC1 promotes malignant progression of nephroblastoma via the Wnt/β‑catenin signaling pathway.

Authors:  Geng Geng; Qinghao Li; Xingqing Guo; Qingbin Ni; Yongtao Xu; Zhaolong Ma; Yongjin Wang; Ming Ming
Journal:  Mol Med Rep       Date:  2022-07-07       Impact factor: 3.423

4.  Inhibitory effect of STAT3 gene combined with CDDP on growth of human Wilms tumour SK-NEP-1 cells.

Authors:  Junrong Wang; Nina Zhang; Haijiang Qu; Guangxian You; Junhui Yuan; Caie Chen; Wenyi Li; Feng Pan
Journal:  Biosci Rep       Date:  2016-06-03       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.